申请人:BEECHAM GROUP PLC
公开号:EP0045219A1
公开(公告)日:1982-02-03
A compound of the formula (I) and pharmaceutically acceptable salts thereof:
wherein:
Ar is phenyl, optionally substituted by one or more C1-4 alkyl, C1-4 alkoxy, halogen, cyano, nitro, hydroxy, CONH2, C02W wherein W ist C1-6 alkyl of C1-4 alkylphenyl which phenyl may be substituted by one or more C1-4 alkyl, C1-4 alkoxy or halogen, NR1R2 wherein R1 and R2 are selected from hydrogen or C1-6 alkyl, NHCO C1-6 alkyl or C1-6 alkylcarbonyloxy; phenyl disubstituted on adjacent carbon atoms by methylenedioxy; furyl or thienyl;
the dotted lines represent an optionally present double bond; and
X is CO or CR1OH wherein R1 is hydrogen or C1-4 alkyl, having useful pharmacological activity, processes for their preparation and their use.
式 (I) 的化合物及其药学上可接受的盐类:
其中
Ar 是苯基,可任选被一个或多个 C1-4 烷基、C1-4 烷氧基、卤素、氰基、硝基、羟基、CONH2、C02W(其中 Wt 是 C1-6 烷基的 C1-4 烷基苯基,苯基可被一个或多个 C1-4 烷基、C1-4 烷氧基或卤素取代)、NR1R2(其中 R1 和 R2 选自氢或 C1-6 烷基、NHCO C1-6 烷基或 C1-6 烷基羰氧基)、在相邻碳原子上被亚甲基二氧基、呋喃基或噻吩基取代的苯基;
虚线代表任选存在的双键;以及
X是CO或CR1OH,其中R1是氢或C1-4烷基。